Is A Rise Imminent For Merck Stock After An 8% Fall In A Month?

Is A Rise Imminent For Merck Stock After An 8% Fall In A Month?

The stock price of Merck has seen an 8% fall in a month, while it was down nearly 4% on Friday, Nov 26. This can largely be attributed to the company’s recently shared data for its Covid-19 antiviral pill – Molnupiravir – which shows lower efficacy of 30% against hospitalization and death in high…